• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

曼泽明 A 改变体外颅骨成骨细胞功能。

Manzamine-A Alters In Vitro Calvarial Osteoblast Function.

机构信息

Department of Biomedical Education and Anatomy, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.

Chemistry Department, Faculty of Science, University of Malaya, Kuala Lumpur 50603, Malaysia.

出版信息

Mar Drugs. 2022 Oct 19;20(10):647. doi: 10.3390/md20100647.

DOI:10.3390/md20100647
PMID:36286470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9604769/
Abstract

Manzamine-A is a marine-derived alkaloid which has anti-viral and anti-proliferative properties and is currently being investigated for its efficacy in the treatment of certain viruses (malaria, herpes, HIV-1) and cancers (breast, cervical, colorectal). Manzamine-A has been found to exert effects via modulation of SIX1 gene expression, a gene critical to craniofacial development via the WNT, NOTCH, and PI3K/AKT pathways. To date little work has focused on Manzamine-A and how its use may affect bone. We hypothesize that Manzamine-A, through SIX1, alters bone cell activity. Here, we assessed the effects of Manzamine-A on cells that are responsible for the generation of bone, pre-osteoblasts and osteoblasts. PCR, qrtPCR, MTS cell viability, Caspase 3/7, and functional assays were used to test the effects of Manzamine-A on these cells. Our data suggests Six1 is highly expressed in osteoblasts and their progenitors. Further, osteoblast progenitors and osteoblasts exhibit great sensitivity to Manzamine-A treatment exhibited by a significant decrease in cell viability, increase in cellular apoptosis, and decrease in alkaline phosphatase activity. In silico binding experiment showed that manzamine A potential as an inhibitor of cell proliferation and survival proteins, i.e., Iκb, JAK2, AKT, PKC, FAK, and Bcl-2. Overall, our data suggests Manzamine-A may have great effects on bone health overall and may disrupt skeletal development, homeostasis, and repair.

摘要

曼扎胺-A 是一种海洋衍生的生物碱,具有抗病毒和抗增殖特性,目前正在研究其在治疗某些病毒(疟疾、疱疹、HIV-1)和癌症(乳腺癌、宫颈癌、结直肠癌)方面的疗效。曼扎胺-A 通过调节 SIX1 基因表达发挥作用,SIX1 基因是颅面发育过程中通过 WNT、NOTCH 和 PI3K/AKT 途径的关键基因。迄今为止,很少有研究关注曼扎胺-A 及其使用如何影响骨骼。我们假设曼扎胺-A 通过 SIX1 改变骨细胞的活性。在这里,我们评估了曼扎胺-A 对负责产生骨骼的细胞(成骨前体细胞和成骨细胞)的影响。PCR、qrtPCR、MTS 细胞活力、Caspase 3/7 和功能测定用于测试曼扎胺-A 对这些细胞的影响。我们的数据表明,SIX1 在成骨细胞及其祖细胞中高度表达。此外,成骨细胞前体细胞和成骨细胞对曼扎胺-A 治疗非常敏感,表现为细胞活力显著降低、细胞凋亡增加和碱性磷酸酶活性降低。计算机结合实验表明,曼扎胺 A 可能是一种抑制细胞增殖和存活蛋白的潜在物质,即 Iκb、JAK2、AKT、PKC、FAK 和 Bcl-2。总的来说,我们的数据表明曼扎胺-A 可能对整体骨骼健康有很大影响,并可能破坏骨骼发育、平衡和修复。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25e7/9604769/c2d92feb8ef1/marinedrugs-20-00647-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25e7/9604769/afc3c0140a91/marinedrugs-20-00647-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25e7/9604769/0c5b9ae9a5f5/marinedrugs-20-00647-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25e7/9604769/bfea5b90f63c/marinedrugs-20-00647-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25e7/9604769/930ee55c00c4/marinedrugs-20-00647-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25e7/9604769/fb1c55831580/marinedrugs-20-00647-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25e7/9604769/c2d92feb8ef1/marinedrugs-20-00647-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25e7/9604769/afc3c0140a91/marinedrugs-20-00647-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25e7/9604769/0c5b9ae9a5f5/marinedrugs-20-00647-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25e7/9604769/bfea5b90f63c/marinedrugs-20-00647-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25e7/9604769/930ee55c00c4/marinedrugs-20-00647-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25e7/9604769/fb1c55831580/marinedrugs-20-00647-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25e7/9604769/c2d92feb8ef1/marinedrugs-20-00647-g006.jpg

相似文献

1
Manzamine-A Alters In Vitro Calvarial Osteoblast Function.曼泽明 A 改变体外颅骨成骨细胞功能。
Mar Drugs. 2022 Oct 19;20(10):647. doi: 10.3390/md20100647.
2
Manzamine-A Alters Calvarial Osteoclast Function.曼泽明-A 改变颅骨破骨细胞功能。
J Nat Prod. 2024 Mar 22;87(3):560-566. doi: 10.1021/acs.jnatprod.3c01097. Epub 2024 Feb 21.
3
Photobiomodulation by Near-Infrared 980-nm Wavelengths Regulates Pre-Osteoblast Proliferation and Viability through the PI3K/Akt/Bcl-2 Pathway.近红外 980nm 波长的光生物调节通过 PI3K/Akt/Bcl-2 通路调节前成骨细胞增殖和活力。
Int J Mol Sci. 2021 Jul 15;22(14):7586. doi: 10.3390/ijms22147586.
4
Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT.Wnt蛋白通过涉及Src/ERK和磷脂酰肌醇3激酶/AKT的β-连环蛋白依赖性和非依赖性信号级联反应,防止未分化的成骨细胞祖细胞和分化的成骨细胞凋亡。
J Biol Chem. 2005 Dec 16;280(50):41342-51. doi: 10.1074/jbc.M502168200. Epub 2005 Oct 25.
5
Daidzein stimulates osteogenesis facilitating proliferation, differentiation, and antiapoptosis in human osteoblast-like MG-63 cells via estrogen receptor-dependent MEK/ERK and PI3K/Akt activation.大豆苷元通过雌激素受体依赖性的MEK/ERK和PI3K/Akt激活,刺激人成骨样MG-63细胞的成骨作用,促进其增殖、分化和抗凋亡。
Nutr Res. 2017 Jun;42:20-30. doi: 10.1016/j.nutres.2017.04.009. Epub 2017 May 6.
6
Dexamethasone suppresses osteogenesis of osteoblast the PI3K/Akt signaling pathway and .地塞米松抑制成骨细胞的成骨作用、PI3K/Akt信号通路以及……(原文此处不完整)
J Recept Signal Transduct Res. 2019 Feb;39(1):80-86. doi: 10.1080/10799893.2019.1625061. Epub 2019 Jun 18.
7
Calycosin stimulates the osteogenic differentiation of rat calvarial osteoblasts by activating the IGF1R/PI3K/Akt signaling pathway.毛蕊异黄酮通过激活 IGF1R/PI3K/Akt 信号通路来刺激大鼠颅骨成骨细胞的成骨分化。
Cell Biol Int. 2019 Mar;43(3):323-332. doi: 10.1002/cbin.11102. Epub 2019 Jan 29.
8
Insulin improves osteogenesis of titanium implants under diabetic conditions by inhibiting reactive oxygen species overproduction via the PI3K-Akt pathway.胰岛素通过PI3K-Akt途径抑制活性氧的过度产生,从而改善糖尿病条件下钛植入物的骨生成。
Biochimie. 2015 Jan;108:85-93. doi: 10.1016/j.biochi.2014.10.004. Epub 2014 Oct 13.
9
c-Abl-dependent molecular circuitry involving Smad5 and phosphatidylinositol 3-kinase regulates bone morphogenetic protein-2-induced osteogenesis.c-Abl 依赖性分子电路涉及 Smad5 和磷脂酰肌醇 3-激酶调节骨形态发生蛋白 2 诱导的成骨作用。
J Biol Chem. 2013 Aug 23;288(34):24503-17. doi: 10.1074/jbc.M113.455733. Epub 2013 Jul 2.
10
Inhibition of miR‑98‑5p promotes high glucose‑induced suppression of preosteoblast proliferation and differentiation via the activation of the PI3K/AKT/GSK3β signaling pathway by targeting BMP2.抑制 miR-98-5p 通过靶向 BMP2 激活 PI3K/AKT/GSK3β 信号通路促进高糖诱导的前成骨细胞增殖和分化抑制。
Mol Med Rep. 2022 Sep;26(3). doi: 10.3892/mmr.2022.12808. Epub 2022 Jul 29.

引用本文的文献

1
Exploring manzamine a: a promising anti-lung cancer agent from marine sponge sp.探索海人草胺A:一种来自海洋海绵的有前景的抗肺癌药物
Front Pharmacol. 2025 Feb 25;16:1525210. doi: 10.3389/fphar.2025.1525210. eCollection 2025.
2
Manzamine-A Alters Calvarial Osteoclast Function.曼泽明-A 改变颅骨破骨细胞功能。
J Nat Prod. 2024 Mar 22;87(3):560-566. doi: 10.1021/acs.jnatprod.3c01097. Epub 2024 Feb 21.

本文引用的文献

1
Thiaplakortone B attenuates RANKL-induced NF-κB and MAPK signaling and dampens OVX-induced bone loss in mice.噻帕拉酮 B 可抑制 RANKL 诱导的 NF-κB 和 MAPK 信号通路,缓解去卵巢小鼠的骨丢失。
Biomed Pharmacother. 2022 Oct;154:113622. doi: 10.1016/j.biopha.2022.113622. Epub 2022 Sep 7.
2
Contemporary Approaches to the Discovery and Development of Broad-Spectrum Natural Product Prototypes for the Control of Coronaviruses.当代广谱天然产物原型物用于冠状病毒防控的发现与开发方法。
J Nat Prod. 2021 Nov 26;84(11):3001-3007. doi: 10.1021/acs.jnatprod.1c00625. Epub 2021 Oct 22.
3
RSK1 vs. RSK2 Inhibitory Activity of the Marine β-Carboline Alkaloid Manzamine A: A Biochemical, Cervical Cancer Protein Expression, and Computational Study.
海洋β-咔啉生物碱马尼胺 A 对 RSK1 和 RSK2 的抑制活性:生化、宫颈癌蛋白表达和计算研究。
Mar Drugs. 2021 Sep 7;19(9):506. doi: 10.3390/md19090506.
4
Recent advances in management of COVID-19: A review.近期 COVID-19 管理进展:综述。
Biomed Pharmacother. 2021 Nov;143:112107. doi: 10.1016/j.biopha.2021.112107. Epub 2021 Aug 27.
5
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment.用于 COVID-19 预防和治疗的 SARS-CoV-2 中和抗体。
Annu Rev Med. 2022 Jan 27;73:1-16. doi: 10.1146/annurev-med-042420-113838. Epub 2021 Aug 24.
6
Recent updates on immunological, pharmacological, and alternative approaches to combat COVID-19.关于免疫、药理学和对抗 COVID-19 的替代方法的最新进展。
Inflammopharmacology. 2021 Oct;29(5):1331-1346. doi: 10.1007/s10787-021-00850-7. Epub 2021 Jul 30.
7
Prescription medications for use in pregnancy-perspective from the US Food and Drug Administration.妊娠期处方药物使用——来自美国食品药品监督管理局的视角。
Am J Obstet Gynecol. 2021 Jul;225(1):21-32. doi: 10.1016/j.ajog.2021.02.032.
8
Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer.天然产物单独或与美国食品药品监督管理局(FDA)批准的药物联合使用,用于治疗新冠肺炎和肺癌。
Biomedicines. 2021 Jun 18;9(6):689. doi: 10.3390/biomedicines9060689.
9
Repurposing Interleukin-6 Inhibitors to Combat COVID-19.重新利用白细胞介素-6抑制剂来对抗新冠病毒。
J Immunother Precis Oncol. 2020;3(2):52-55. doi: 10.36401/jipo-20-11. Epub 2020 May 22.
10
A Mini Review on Discovery and Synthesis of Remdesivir as an Effective and Promising Drug against COVID-19.关于瑞德西韦作为一种对抗新冠病毒的有效且有前景药物的发现与合成的综述
Russ J Bioorg Chem. 2021;47(3):609-621. doi: 10.1134/S1068162021030183. Epub 2021 Jun 11.